Composition
- Active ingredients
- CHLORPROTHIXENE 12.5MG/ML
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CHLORPROTHIXENE 12.5MG/ML · InjectableThis page
- CHLORPROTHIXENE 100MG/5ML · ConcentrateNDA016149-002 · Discontinued
- CHLORPROTHIXENE 100MG · TabletNDA012486-001 · Discontinued
- CHLORPROTHIXENE 25MG · TabletNDA012486-004 · Discontinued
- CHLORPROTHIXENE 10MG · TabletNDA012486-005 · Discontinued
- CHLORPROTHIXENE 50MG · TabletNDA012486-003 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA012487.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Taractan
- Active substance
- chlorprothixene
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Roche
- Status
- Discontinued
- FDA approval
- 23 Mar 1962
- Application
- NDA012487-001